SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sivakesava Files Form 3 for CRISPR Therapeutics

A Form 3 for CRISPR Therapeutics AG was filed by Sakhamuri Sivakesava on Nov. 2.

CRSP

Related stories